Search

Your search keyword '"Edahiro, Yoko"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Edahiro, Yoko" Remove constraint Author: "Edahiro, Yoko" Database Academic Search Index Remove constraint Database: Academic Search Index
28 results on '"Edahiro, Yoko"'

Search Results

1. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan.

2. A cross-sectional survey of symptoms and daily living among patients with polycythemia vera and their treating physicians in Japan.

3. Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.

4. Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.

5. Skewed megakaryopoiesis in human induced pluripotent stem cell‐derived haematopoietic progenitor cells harbouring calreticulin mutations.

6. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis.

7. Establishment of isogenic induced pluripotent stem cells with or without pathogenic mutation for understanding the pathogenesis of myeloproliferative neoplasms.

8. A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera.

9. Successful perioperative management of factor XI deficiency with administration of fresh-frozen plasma in a subdural hematoma patient.

10. Impact of non‐driver gene mutations on thrombo‐haemorrhagic events in ET patients.

11. MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.

12. Evaluation of bone marrow aspirates using the automated hematology analyzer Sysmex XN‐3000.

13. Non‐driver gene mutation analysis in a large cohort of polycythemia vera and essential thrombocythemia.

14. Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non‐neoplastic erythrocytosis patients.

15. Validation and reliability of current guidelines for the treatment of essential thrombocythemia under real-world clinical settings in Japan.

16. Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.

17. Author Correction: Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.

18. Hodgkin Lymphoma on Hemodialysis Successfully Treated with Extended Courses of Brentuximab Vedotin.

19. Cell-autonomous megakaryopoiesis associated with polyclonal hematopoiesis in triple-negative essential thrombocythemia.

20. Radiation-Induced Myopathy Developing in a Hodgkin Lymphoma Patient: An Autopsy Case with Systemic Muscle Sampling.

21. Difficulty Diagnosing a Brain Tumor during Clinical Maintenance of a Complete Response to anti-HER2 Treatments for Metastatic Breast Cancer: A Case Report.

22. JAK2 exon 12 mutation in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis: Not an exclusive mutation to polycythaemia vera.

23. Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: two case reports and a literature review.

24. The 2014 BCSH criteria and the 2016 WHO criteria for essential thrombocythemia: A comparison in a large-scale cohort.

25. Activation of the thrombopoietin receptor by mutant calreticulin in CALR-mutant myeloproliferative neoplasms.

26. Melting Curve Analysis after T Allele Enrichment (MelcaTle) as a Highly Sensitive and Reliable Method for Detecting the JAK2V617F Mutation.

27. Detection of MPLW515L/K Mutations and Determination of Allele Frequencies with a Single-Tube PCR Assay.

28. Inhibition of the NAD-Dependent Protein Deacetylase SIRT2 Induces Granulocytic Differentiation in Human Leukemia Cells.

Catalog

Books, media, physical & digital resources